Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Press Releases

Press Releases

167 results

Sort 167 results by:

Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Reset All Filters
CLI logo
Press Releases

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to…

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
Please login to bookmark Close
Press Releases

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection…

CLI logo
Press Releases

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through…

CLI logo
Press Releases

Charlotte Lozier Institute Responses to Sage Retractions

The Charlotte Lozier Institute (CLI) and associate scholars are facing an unprecedented attack on our research. We believe that because…

Press Releases

Study: Women Report Abortion Drug as More Difficult Choice Than Abortion Pill Reversal

Women experience high degree of internal turmoil, regret upon taking mifepristone

Press Releases

Pregnancy Centers Provided Over $350M of Services & Goods 

Meeting the Needs of Families in the Dobbs Era 

Press Releases

Study: Abortion in First Pregnancy Linked to Much Higher Use of Mental Health Services

Women whose first pregnancy ends in abortion have much larger increases in mental health treatment compared to those who had…

Press Releases

Hidden Epidemic: Nearly 70% of Abortions Are Coerced, Unwanted or Inconsistent With Women’s Preferences

Nearly 70% of women with a history of abortion describe their abortions as inconsistent with their own values and preferences,…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image